| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Collegium Pharmaceutical, Inc. (COLL) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. COLL is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.13M | $120.89M | - | |
| CFO | 126.7K | $4.89M | - | |
| VP | 121.2K | $4.68M | - | |
| CEO | 97.0K | $3.74M | - | |
| Dir | 95.0K | $3.67M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Dieter David | EVP &General Counsel | Sell | 13,976 | $34.92 | $488,099.22 | -15.4% | - | - | |
| Mar 9, 2026 | Dieter David | EVP &General Counsel | Sell | 6,224 | $36.65 | $228,109.60 | -6.4% | - | - | |
| Dec 8, 2025 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sale+OE | 17,600 | $48.17 | $847,855.20 | -7.6% | -22.2% | - | |
| Dec 5, 2025 | Balice-Gordon Rita J. | Director | Sell | 3,650 | $47.03 | $171,673.37 | -6.5% | -22.1% | - | |
| Nov 12, 2025 | Fallon John A. | Director | Sale+OE | 34,853 | $47.21 | $1,645,535.60 | -35.0% | -1.3% | - | |
| Nov 6, 2025 | Tupper Colleen45 | EVP &Chief Financial Officer | Sell | 30,000 | $40.53 | $1,215,753.34 | -10.4% | +18.5% | - | |
| Aug 29, 2025 | Smith Thomas B60 | EVP And Chief Medical Officer | Sell | 17,478 | $38.42 | $671,576.42 | -19.9% | +20.3% | - | |
| Aug 18, 2025 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sale+OE | 16,389 | $38.21 | $626,171.25 | -13.7% | +18.7% | - | |
| Aug 15, 2025 | Santini Gino | Director | Sale+OE | 5,405 | $37.19 | $201,018.44 | -5.4% | +22.9% | - | |
| Aug 13, 2025 | Dreyer Scott54 | EVP &Chief Commercial Officer | Sale+OE | 4,861 | $38.03 | $184,880.84 | -4.5% | +18.4% | - |